Alcon Inc Revenue Growth Rates (ALC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Alcon inc   (NYSE: ALC)
 

ALC's Revenue Growth by Quarter and Year

Alcon Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALC Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 10,401.00
3rd Quarter September 0.00
2nd Quarter June 2,596.00
1st Quarter March 0.00
FY 12,997.00

ALCs Annual Revenue
Alcon Inc 's Revenue in the fiscal year 2025 $ 10,401.00 millions
Alcon Inc 's Revenue in the fiscal year 2024 $ 9,911.00 millions
Alcon Inc 's Revenue in the fiscal year 2023 $ 9,455.00 millions
Alcon Inc 's Revenue in the fiscal year 2022 $ 8,717.00 millions
Alcon Inc 's Revenue in the fiscal year 2021 $ 8,291.00 millions




ALC Revenue fourth quarter 2025 Y/Y Growth Comment
Alcon inc reported Revenue growth of 4.94% year on year in the fourth quarter 2025, to $ 10,401.00 millions, this is lower than Alcon Inc 's recent average Revenue growth of 5.95%.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 79 other companies have achieved higher Revenue growth. While Alcon Inc ' s Revenue increase of 4.94% ranks overall at the positon no. 1745 in the fourth quarter 2025.


ALC Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December 4.94 % 4.82 % 8.47 % 5.14 %
3rd Quarter September - - - -
2nd Quarter June 4.01 % 3.06 % 9.25 % 5.07 %
1st Quarter March - - - -
FY   4.76 % 4.46 % 8.62 % -

Financial Statements
Alcon Inc 's fourth quarter 2025 Revenue $ 10,401.00 millions ALC's Income Statement
Alcon Inc 's fourth quarter 2024 Revenue $ 9,911.00 millions Quarterly ALC's Income Statement


ALC Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   4.76 % 4.46 % 8.62 % -


Back to ALC Growth rate Comparisons >> Back to ALC Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #80
Healthcare Sector #273
Overall #1745

Revenue Y/Y Growth Statistics
High Average Low
21.34 % 5.95 % -8.99 %
(Dec 31 2021)   (Dec 31 2020)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #80
Healthcare Sector #273
Overall #1745
Revenue Y/Y Growth Statistics
High Average Low
21.34 % 5.95 % -8.99 %
(Dec 31 2021)   (Dec 31 2020)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Alcon Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALC's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALC's IV. Quarter Q/Q Revenue Comment


Alcon Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 10,401.00 $ 9,911.00 $ 9,455.00 $ 8,717.00 $ 8,291.00
Y / Y Revenue Growth (TTM) 4.94 % 4.82 % 8.47 % 5.14 % 21.34 %
Year on Year Revenue Growth Overall Ranking # 394 # 754 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 4.94 % 4.82 % 8.47 % 5.14 % 21.34 %
Seq. Revenue Growth (TTM) Overall Ranking # 394 # 753 # 0 # 0 # 0


Cumulative Revenue growth Comment
Although Alcon Inc 's Annual Revenue growth year on year were below company's average 6.49% , Revenue announced in the Dec 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 4.94% year on year, from 4.82% in Dec 31 2024.

In the Healthcare sector 89 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 394, from total ranking in previous quarter at 754.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 19
Healthcare Sector # 90
Overall # 394

Revenue TTM Y/Y Growth Statistics
High Average Low
21.34 %
 6.49 %
-8.99 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 19
Sector # 90
S&P 500 # 394
Cumulative Revenue growth Comment
Although Alcon Inc 's Annual Revenue growth year on year were below company's average 6.49% , Revenue announced in the Dec 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 4.94% year on year, from 4.82% in Dec 31 2024.

In the Healthcare sector 89 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 394, from total ranking in previous quarter at 754.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 19
Healthcare Sector # 90
Overall # 394

Revenue TTM Y/Y Growth Statistics
High Average Low
21.34 %
6.49 %
-8.99 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 19
Sector # 90
S&P 500 # 394




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ALC's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Option Care Health Inc 8.63%$ 8.631 millions
Astrazeneca Plc8.63%$ 8.629 millions
Amgen Inc 8.58%$ 8.585 millions
Integer Holdings Corporation8.38%$ 8.377 millions
Vivosim Labs Inc 8.33%$ 8.333 millions
China Pharma Holdings Inc8.11%$ 8.113 millions
Novocure Limited8.11%$ 8.113 millions
Mettler toledo International Inc 8.10%$ 8.095 millions
Yunhong Green Cti Ltd 8.03%$ 8.028 millions
Baxter International Inc 8.03%$ 8.028 millions
Nuwellis Inc 8.02%$ 8.021 millions
Conmed Corporation7.88%$ 7.878 millions
Ardelyx inc 7.82%$ 7.824 millions
Henry Schein Inc 7.71%$ 7.709 millions
West Pharmaceutical Services Inc 7.65%$ 7.654 millions
Catalyst Pharmaceuticals Inc 7.61%$ 7.610 millions
Vanda Pharmaceuticals Inc 7.58%$ 7.579 millions
Stevanato Group S p a 7.45%$ 7.450 millions
United Therapeutics Corporation7.38%$ 7.379 millions
Fulgent Genetics Inc 7.36%$ 7.364 millions
Icon Plc7.29%$ 7.287 millions
Adm Tronics Unlimited Inc 7.15%$ 7.148 millions
Quest Diagnostics Inc7.06%$ 7.058 millions
Infusystem Holdings Inc7.04%$ 7.037 millions
Pluri Inc 7.03%$ 7.027 millions
Sinovac Biotech Ltd7.01%$ 7.013 millions
Ge Healthcare Technologies Inc 6.87%$ 6.865 millions
Waters Corporation6.83%$ 6.835 millions
Progyny Inc 6.83%$ 6.829 millions
Alpha Pro Tech Ltd 6.73%$ 6.730 millions


About Alcon Inc Revenue Growth Rates (ALC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Alcon Inc (CIK 1167379).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001167379-26-000014
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Alcon Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.